Becton Dickinson Profit Margin 2010-2022 | BDX

Current and historical gross margin, operating margin and net profit margin for Becton Dickinson (BDX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Becton Dickinson net profit margin as of March 31, 2022 is 9.59%.
Becton Dickinson Annual Profit Margins
Becton Dickinson Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $70.676B $20.248B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $46.288B 13.61
AmerisourceBergen (ABC) United States $29.474B 13.60
West Pharmaceutical Services (WST) United States $22.672B 34.54
Laboratory Of America Holdings (LH) United States $22.247B 9.29
Cooper (COO) United States $15.585B 23.99
Cardinal Health (CAH) United States $14.234B 10.93
CONMED (CNMD) United States $2.863B 29.57
Invacare (IVC) United States $0.048B 0.00